Clinical Trial Update: Study of cPMP (Precusor Z) to Treat Molybdenum Cofactor Deficiency (MoCD) Type A [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/2 clinical trial of cPMP (Precursor Z) for Molybdenum Cofactor Deficiency Type A has been withdrawn by the sponsor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Molybdenum Cofactor Deficiency Type

Drugs mentioned

• cPMP (Precursor Z)

Snippet

Sponsor: Orphatech Pharmaceuticals, GmbH | Conditions: Molybdenum Cofactor Deficiency Type A | Phase 1, Phase 2 | Status: WITHDRAWN